A biopharmaceutical company focuses on the discovery, development and commercialization of innovative treatments for infectious diseases
The best Bull and Bear pitches based on recency and number of recommendations.
Hot momentum stock in the Biotech sector. Great way to pick up the strength in the Biotechs.
The company's entire net worth is due to last year's financing. The company will continue to lose cash and financial flexibility unless it gets bought out. Given the performance recently, I expect the stock to drop back down to $4.
Read the most recent pitches from players about ACHN.DL.
Find the members with the highest scoring picks in ACHN.DL.
See what the Wall Street professionals think, according to their public statements and filings.